PolyPid Granted Fast Track Designation from FDA for D-PLEXa?a??a?? for Prevention of Surgical Site Infections in Abdominal Surgery

Source :: GlobeNewswire. August 3, 2020
Publication Year :: 2020
Abstract: PETAH TIKVA, Israel, Aug 03, 2020 (GLOBE NEWSWIRE via COMTEX) -- PolyPid Ltd. (Nasdaq: PYPD), a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics [...]

Subjects :: United States. Food and Drug Administration
Surgery -- Health aspects
Infection -- Drug therapy
Banking, finance and accounting industries
Business

Tools